US Supreme Court to take up diagnostic test patent case
This article was originally published in SRA
Executive Summary
The US Supreme Court has agreed to hear an appeal by the Mayo Clinic challenging the patentability of a test used to determine proper drug dosing in a case that could create a firestorm for personalised medicine and diagnostic method inventions1.